{"nct_id":"NCT05077709","title":"IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-07","start_date":"2022-02-14","start_date_type":"ACTUAL","primary_completion_date":"2024-01-04","primary_completion_date_type":"ACTUAL","completion_date":"2024-11-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["IOBT"]}